Page last updated: 2024-08-22

n-methylaspartate and Astrocytoma, Grade IV

n-methylaspartate has been researched along with Astrocytoma, Grade IV in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Altinoz, MA; Hacker, E; Ozpinar, A1
Ashkenazi, S; Berent, E; Weizman, A; Yuhas, Y1
Ishiuchi, S1
Bertalanffy, H; Capper, D; Frei, K; Goeppert, B; Harter, P; Lang, F; Lupescu, A; Meyermann, R; Mittelbronn, M; Schilbach, K; Simon, P; Vollmann, H; Warth, A; Weller, M1

Reviews

1 review(s) available for n-methylaspartate and Astrocytoma, Grade IV

ArticleYear
A hypothetical proposal to employ meperidine and tamoxifen in treatment of glioblastoma. Role of P-glycoprotein, ceramide and metabolic pathways.
    Clinical neurology and neurosurgery, 2022, Volume: 215

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ceramides; Glioblastoma; Humans; Meperidine; Metabolic Networks and Pathways; N-Methylaspartate; Tamoxifen

2022

Other Studies

3 other study(ies) available for n-methylaspartate and Astrocytoma, Grade IV

ArticleYear
Ketamine upregulates eNOS expression in human astroglial A172 cells: Possible role in its antidepressive properties.
    Journal of neuroimmunology, 2017, 04-15, Volume: 305

    Topics: Astrocytes; Cell Line, Transformed; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glioblastoma; Humans; Immunosuppressive Agents; Ketamine; MAP Kinase Signaling System; N-Methylaspartate; Nitric Oxide Synthase Type III; RNA, Messenger; Sirolimus; Time Factors; Up-Regulation; Valine

2017
[Development of a novel targeted therapy for human glioblastoma].
    No shinkei geka. Neurological surgery, 2003, Volume: 31, Issue:5

    Topics: Brain Neoplasms; Excitatory Amino Acid Antagonists; Glioblastoma; Humans; N-Methylaspartate; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate

2003
EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomas.
    Brain pathology (Zurich, Switzerland), 2009, Volume: 19, Issue:2

    Topics: Astrocytoma; Brain; Brain Neoplasms; Calcium; Cell Line, Tumor; Early Growth Response Protein 1; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Multivariate Analysis; N-Methylaspartate; Polymerase Chain Reaction; Protein Isoforms; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Tumor Cells, Cultured

2009